Somatic Systems, Inc. (PINKSHEETS: SMAS), a leader in the field of pain management, today released a letter to shareholders from Chief Executive Officer Steven Aronstein. In the letter, Aronstein reviews the company's efforts of the past year and the present and future growth these efforts provide.

The letter is featured in the new Investor Relations section of their web site, at http://www.somatics.org/investors/letters/2009/04/07.

Topics of the letter include media coverage (including television features airing to over 300 million households nationally and internationally) of Somatic Systems and their Clinical Somatics pain care system, as well as other marketing efforts and expansion milestones. Also discussed are the company's exciting involvement with the US military. The company also discusses issues of share retirements, and shares its current activities for increased expansion and revenues.

The company also states that this will be one of many updates shareholders will see going forward, as they resume a more active schedule of releases, conference calls, and other communications with shareholders.

About Somatic Systems, Inc.

Somatic Systems is the worldwide center for Clinical Somatics(TM), the ground-breaking drug-free, non-surgical approach to pain relief. This proprietary system uses natural, non-invasive movement techniques -- conducted through one-hour hands-on sessions, therapeutic exercise classes, and home exercises lasting as little as 5 minutes a day -- to relieve pain and limitation resulting from accident, trauma and repetitive stress, including back pain, knee pain, joint problems, carpal tunnel syndrome, TMJ, scoliosis, bursitis, sciatica, headaches, tendonitis and more. Clinical Somatics(TM) also provides performance gains and injury prevention for casual and professional athletes.

Somatic Systems is pursuing a 3-part growth strategy, consisting of a nationwide rollout of pain management Somatics Clinics; increased production and distribution of therapeutic videos, books, and other retail self-help Somatics Products; and expanded Somatics Training Programs to supply Clinic practitioners serving medical and orthopedic professionals and institutional and corporate programs. The company operates a suite of web sites offering Somatics information, products, resources, and opportunities, at www.somatics.org.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Contact: For more information visit http://www.somatics.org or contact: Investor Relations 1 877 586-2555

Somatic Systems (CE) (USOTC:SMAS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Somatic Systems (CE) 차트를 더 보려면 여기를 클릭.
Somatic Systems (CE) (USOTC:SMAS)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Somatic Systems (CE) 차트를 더 보려면 여기를 클릭.